Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Jonkman

Showing results (71-80 of 151) with videos related to

Pageof 16
Sort By:
The British Journal of Dermatology|July 24, 2004
U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseasesR M Vodegel, M F Jonkman, H H Pas, et al.
The British Journal of Dermatology|November 12, 2015
Direct and indirect immunofluorescence staining patterns in the diagnosis of paraneoplastic pemphigusA M Poot, J Siland, M F Jonkman, et al.
Clinical and Experimental Dermatology|August 12, 2006
Human orf complicated by mucous membrane pemphigoidR G van Lingen, R G J Frank, R J J Koopman, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 15, 2001
Truncated typeXVII collagen expression in a patient with non-herlitz junctional epidermolysis bullosa caused by a homozygous splice-site mutationM R van Leusden, H H Pas, T Gedde-Dahl, et al.
The British Journal of Dermatology|October 23, 2018
Combined tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a report of three casesN H B Schräder, J C Duipmans, B Molenbuur, et al.
The British Journal of Dermatology|May 16, 2019
Keratinocyte footprint assay discriminates antilaminin-332 pemphigoid from all other forms of pemphigoid diseasesF Giurdanella, A M Nijenhuis, G F H Diercks, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 5, 1998
LAMB3 mutations in generalized atrophic benign epidermolysis bullosa: consequences at the mRNA and protein levelsL Pulkkinen, M F Jonkman, J A McGrath, et al.
Rheumatology (Oxford, England)|December 15, 2005
Skin sensitivity to UVB irradiation in systemic lupus erythematosus is not related to the level of apoptosis induction in keratinocytesE Reefman, H Kuiper, M F Jonkman, et al.
The British Journal of Dermatology|May 7, 2009
Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapyA Gostynski, F C L Deviaene, A M G Pasmooij, et al.
The British Journal of Dermatology|August 13, 2014
Somatic mosaicism for the COL7A1 mutation p.Gly2034Arg in the unaffected mother of a patient with dystrophic epidermolysis bullosa pruriginosaP C van den Akker, A M G Pasmooij, R Meijer, et al.
Pageof 16

Showing results (71-80 of 151) with videos related to

Sort By:
Pageof 16
The British Journal of Dermatology|July 24, 2004
U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseasesR M Vodegel, M F Jonkman, H H Pas, et al.
The British Journal of Dermatology|November 12, 2015
Direct and indirect immunofluorescence staining patterns in the diagnosis of paraneoplastic pemphigusA M Poot, J Siland, M F Jonkman, et al.
Clinical and Experimental Dermatology|August 12, 2006
Human orf complicated by mucous membrane pemphigoidR G van Lingen, R G J Frank, R J J Koopman, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 15, 2001
Truncated typeXVII collagen expression in a patient with non-herlitz junctional epidermolysis bullosa caused by a homozygous splice-site mutationM R van Leusden, H H Pas, T Gedde-Dahl, et al.
The British Journal of Dermatology|October 23, 2018
Combined tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a report of three casesN H B Schräder, J C Duipmans, B Molenbuur, et al.
The British Journal of Dermatology|May 16, 2019
Keratinocyte footprint assay discriminates antilaminin-332 pemphigoid from all other forms of pemphigoid diseasesF Giurdanella, A M Nijenhuis, G F H Diercks, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 5, 1998
LAMB3 mutations in generalized atrophic benign epidermolysis bullosa: consequences at the mRNA and protein levelsL Pulkkinen, M F Jonkman, J A McGrath, et al.
Rheumatology (Oxford, England)|December 15, 2005
Skin sensitivity to UVB irradiation in systemic lupus erythematosus is not related to the level of apoptosis induction in keratinocytesE Reefman, H Kuiper, M F Jonkman, et al.
The British Journal of Dermatology|May 7, 2009
Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapyA Gostynski, F C L Deviaene, A M G Pasmooij, et al.
The British Journal of Dermatology|August 13, 2014
Somatic mosaicism for the COL7A1 mutation p.Gly2034Arg in the unaffected mother of a patient with dystrophic epidermolysis bullosa pruriginosaP C van den Akker, A M G Pasmooij, R Meijer, et al.
Pageof 16